Finally, building on our previous work showing that moDCs can act as antigen-presenting cells that migrate to lymph nodes and induce IL-10-dependent regulatory T cells13, 31, we investigated whether blocking CCR5-dependent monocyte lymph node trafficking during neoantigen vaccination could enhance tumor control. This evidence concerns the gene CCR5 and neoplasm.